-+ 0.00%
-+ 0.00%
-+ 0.00%

US FDA - APPROVES JUVMO (TAVAPADON) FOR PARKINSON’S DISEASE IN ADULTS ON SEPT 25, 2026

Reuters·09/25/2026 21:53:24

Please log in to view news